nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—myometrium—uterine cancer	0.0554	0.17	CbGeAlD
Icosapent ethyl—DGAT1—uterine cervix—uterine cancer	0.0431	0.132	CbGeAlD
Icosapent ethyl—DGAT1—decidua—uterine cancer	0.0411	0.126	CbGeAlD
Icosapent ethyl—DGAT1—endometrium—uterine cancer	0.039	0.12	CbGeAlD
Icosapent ethyl—DGAT1—mammalian vulva—uterine cancer	0.0377	0.116	CbGeAlD
Icosapent ethyl—DGAT1—female reproductive system—uterine cancer	0.0323	0.0991	CbGeAlD
Icosapent ethyl—DGAT1—female gonad—uterine cancer	0.0294	0.0901	CbGeAlD
Icosapent ethyl—DGAT1—vagina—uterine cancer	0.0292	0.0896	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—uterine cancer	0.0189	0.0579	CbGeAlD
Icosapent ethyl—Hyperhidrosis—Progesterone—uterine cancer	0.00185	0.00274	CcSEcCtD
Icosapent ethyl—Fungal infection—Doxorubicin—uterine cancer	0.00184	0.00273	CcSEcCtD
Icosapent ethyl—Anorexia—Progesterone—uterine cancer	0.00182	0.0027	CcSEcCtD
Icosapent ethyl—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00268	CcSEcCtD
Icosapent ethyl—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00268	CcSEcCtD
Icosapent ethyl—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00268	CcSEcCtD
Icosapent ethyl—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00178	0.00265	CcSEcCtD
Icosapent ethyl—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00177	0.00262	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00175	0.0026	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00174	0.00258	CcSEcCtD
Icosapent ethyl—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00257	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00173	0.00257	CcSEcCtD
Icosapent ethyl—Insomnia—Progesterone—uterine cancer	0.00173	0.00256	CcSEcCtD
Icosapent ethyl—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00172	0.00255	CcSEcCtD
Icosapent ethyl—Dysphagia—Etoposide—uterine cancer	0.00172	0.00255	CcSEcCtD
Icosapent ethyl—Chills—Dactinomycin—uterine cancer	0.00171	0.00253	CcSEcCtD
Icosapent ethyl—Dyspnoea—Progesterone—uterine cancer	0.0017	0.00253	CcSEcCtD
Icosapent ethyl—Shock—Medroxyprogesterone Acetate—uterine cancer	0.0017	0.00253	CcSEcCtD
Icosapent ethyl—Viral infection—Epirubicin—uterine cancer	0.0017	0.00252	CcSEcCtD
Icosapent ethyl—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00169	0.00251	CcSEcCtD
Icosapent ethyl—Dyspepsia—Progesterone—uterine cancer	0.00168	0.0025	CcSEcCtD
Icosapent ethyl—Alopecia—Dactinomycin—uterine cancer	0.00168	0.00249	CcSEcCtD
Icosapent ethyl—Cough increased—Epirubicin—uterine cancer	0.00168	0.00249	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.00248	CcSEcCtD
Icosapent ethyl—Decreased appetite—Progesterone—uterine cancer	0.00166	0.00246	CcSEcCtD
Icosapent ethyl—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00165	0.00245	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Progesterone—uterine cancer	0.00165	0.00245	CcSEcCtD
Icosapent ethyl—Constipation—Progesterone—uterine cancer	0.00163	0.00242	CcSEcCtD
Icosapent ethyl—Pain—Progesterone—uterine cancer	0.00163	0.00242	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00158	0.00234	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Progesterone—uterine cancer	0.00157	0.00234	CcSEcCtD
Icosapent ethyl—Viral infection—Doxorubicin—uterine cancer	0.00157	0.00233	CcSEcCtD
Icosapent ethyl—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00157	0.00232	CcSEcCtD
Icosapent ethyl—Neck pain—Epirubicin—uterine cancer	0.00155	0.00231	CcSEcCtD
Icosapent ethyl—Cough increased—Doxorubicin—uterine cancer	0.00155	0.0023	CcSEcCtD
Icosapent ethyl—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00154	0.00229	CcSEcCtD
Icosapent ethyl—Pneumonia—Etoposide—uterine cancer	0.00154	0.00229	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Dactinomycin—uterine cancer	0.00154	0.00228	CcSEcCtD
Icosapent ethyl—Infestation NOS—Etoposide—uterine cancer	0.00153	0.00227	CcSEcCtD
Icosapent ethyl—Infestation—Etoposide—uterine cancer	0.00153	0.00227	CcSEcCtD
Icosapent ethyl—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00152	0.00226	CcSEcCtD
Icosapent ethyl—Acute coronary syndrome—Etoposide—uterine cancer	0.00151	0.00224	CcSEcCtD
Icosapent ethyl—Body temperature increased—Progesterone—uterine cancer	0.00151	0.00224	CcSEcCtD
Icosapent ethyl—Eructation—Epirubicin—uterine cancer	0.00151	0.00224	CcSEcCtD
Icosapent ethyl—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00223	CcSEcCtD
Icosapent ethyl—Myocardial infarction—Etoposide—uterine cancer	0.0015	0.00223	CcSEcCtD
Icosapent ethyl—Melaena—Epirubicin—uterine cancer	0.0015	0.00223	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00222	CcSEcCtD
Icosapent ethyl—Malaise—Dactinomycin—uterine cancer	0.00149	0.00221	CcSEcCtD
Icosapent ethyl—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00148	0.0022	CcSEcCtD
Icosapent ethyl—Colitis—Epirubicin—uterine cancer	0.00147	0.00219	CcSEcCtD
Icosapent ethyl—Fluid retention—Epirubicin—uterine cancer	0.00146	0.00216	CcSEcCtD
Icosapent ethyl—Neck pain—Doxorubicin—uterine cancer	0.00144	0.00213	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00143	0.00212	CcSEcCtD
Icosapent ethyl—Myalgia—Dactinomycin—uterine cancer	0.00141	0.00209	CcSEcCtD
Icosapent ethyl—Eructation—Doxorubicin—uterine cancer	0.0014	0.00207	CcSEcCtD
Icosapent ethyl—Discomfort—Dactinomycin—uterine cancer	0.00139	0.00207	CcSEcCtD
Icosapent ethyl—Neoplasm—Epirubicin—uterine cancer	0.00139	0.00206	CcSEcCtD
Icosapent ethyl—Melaena—Doxorubicin—uterine cancer	0.00139	0.00206	CcSEcCtD
Icosapent ethyl—Asthenia—Progesterone—uterine cancer	0.00137	0.00203	CcSEcCtD
Icosapent ethyl—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.00203	CcSEcCtD
Icosapent ethyl—Colitis—Doxorubicin—uterine cancer	0.00136	0.00202	CcSEcCtD
Icosapent ethyl—Pruritus—Progesterone—uterine cancer	0.00135	0.00201	CcSEcCtD
Icosapent ethyl—Oedema—Dactinomycin—uterine cancer	0.00135	0.002	CcSEcCtD
Icosapent ethyl—Fluid retention—Doxorubicin—uterine cancer	0.00135	0.002	CcSEcCtD
Icosapent ethyl—Infection—Dactinomycin—uterine cancer	0.00134	0.00199	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Epirubicin—uterine cancer	0.00131	0.00194	CcSEcCtD
Icosapent ethyl—Anorexia—Dactinomycin—uterine cancer	0.00129	0.00191	CcSEcCtD
Icosapent ethyl—Neoplasm—Doxorubicin—uterine cancer	0.00128	0.00191	CcSEcCtD
Icosapent ethyl—Dizziness—Progesterone—uterine cancer	0.00126	0.00187	CcSEcCtD
Icosapent ethyl—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00124	0.00184	CcSEcCtD
Icosapent ethyl—Eczema—Epirubicin—uterine cancer	0.00124	0.00184	CcSEcCtD
Icosapent ethyl—Chills—Etoposide—uterine cancer	0.00123	0.00183	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00123	0.00183	CcSEcCtD
Icosapent ethyl—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00182	CcSEcCtD
Icosapent ethyl—Alopecia—Etoposide—uterine cancer	0.00122	0.0018	CcSEcCtD
Icosapent ethyl—Vomiting—Progesterone—uterine cancer	0.00122	0.0018	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Doxorubicin—uterine cancer	0.00121	0.00179	CcSEcCtD
Icosapent ethyl—Rash—Progesterone—uterine cancer	0.0012	0.00179	CcSEcCtD
Icosapent ethyl—Dermatitis—Progesterone—uterine cancer	0.0012	0.00179	CcSEcCtD
Icosapent ethyl—Increased appetite—Epirubicin—uterine cancer	0.00119	0.00176	CcSEcCtD
Icosapent ethyl—Decreased appetite—Dactinomycin—uterine cancer	0.00117	0.00174	CcSEcCtD
Icosapent ethyl—Dysgeusia—Etoposide—uterine cancer	0.00117	0.00174	CcSEcCtD
Icosapent ethyl—Back pain—Etoposide—uterine cancer	0.00116	0.00172	CcSEcCtD
Icosapent ethyl—Pain—Dactinomycin—uterine cancer	0.00116	0.00171	CcSEcCtD
Icosapent ethyl—Eczema—Doxorubicin—uterine cancer	0.00115	0.0017	CcSEcCtD
Icosapent ethyl—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.0017	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Dactinomycin—uterine cancer	0.00111	0.00165	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Etoposide—uterine cancer	0.00111	0.00165	CcSEcCtD
Icosapent ethyl—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00163	CcSEcCtD
Icosapent ethyl—Increased appetite—Doxorubicin—uterine cancer	0.0011	0.00163	CcSEcCtD
Icosapent ethyl—Affect lability—Epirubicin—uterine cancer	0.0011	0.00163	CcSEcCtD
Icosapent ethyl—Migraine—Epirubicin—uterine cancer	0.0011	0.00163	CcSEcCtD
Icosapent ethyl—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00162	CcSEcCtD
Icosapent ethyl—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.00162	CcSEcCtD
Icosapent ethyl—Malaise—Etoposide—uterine cancer	0.00108	0.0016	CcSEcCtD
Icosapent ethyl—Vertigo—Etoposide—uterine cancer	0.00108	0.0016	CcSEcCtD
Icosapent ethyl—Body temperature increased—Dactinomycin—uterine cancer	0.00107	0.00158	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Epirubicin—uterine cancer	0.00106	0.00157	CcSEcCtD
Icosapent ethyl—Mood swings—Epirubicin—uterine cancer	0.00106	0.00157	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Etoposide—uterine cancer	0.00105	0.00156	CcSEcCtD
Icosapent ethyl—Cough—Etoposide—uterine cancer	0.00105	0.00155	CcSEcCtD
Icosapent ethyl—Hypertension—Etoposide—uterine cancer	0.00103	0.00153	CcSEcCtD
Icosapent ethyl—Chest pain—Etoposide—uterine cancer	0.00102	0.00151	CcSEcCtD
Icosapent ethyl—Affect lability—Doxorubicin—uterine cancer	0.00102	0.00151	CcSEcCtD
Icosapent ethyl—Migraine—Doxorubicin—uterine cancer	0.00102	0.00151	CcSEcCtD
Icosapent ethyl—Discomfort—Etoposide—uterine cancer	0.00101	0.00149	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.001	0.00149	CcSEcCtD
Icosapent ethyl—Gastritis—Epirubicin—uterine cancer	0.000987	0.00146	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000983	0.00146	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Doxorubicin—uterine cancer	0.000981	0.00146	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Etoposide—uterine cancer	0.000978	0.00145	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—uterine cancer	0.000977	0.00145	CcSEcCtD
Icosapent ethyl—Infection—Etoposide—uterine cancer	0.000971	0.00144	CcSEcCtD
Icosapent ethyl—Abdominal distension—Epirubicin—uterine cancer	0.00097	0.00144	CcSEcCtD
Icosapent ethyl—Asthenia—Dactinomycin—uterine cancer	0.000969	0.00144	CcSEcCtD
Icosapent ethyl—Influenza—Epirubicin—uterine cancer	0.000964	0.00143	CcSEcCtD
Icosapent ethyl—Asthma—Epirubicin—uterine cancer	0.000964	0.00143	CcSEcCtD
Icosapent ethyl—Dysphagia—Epirubicin—uterine cancer	0.000964	0.00143	CcSEcCtD
Icosapent ethyl—Tachycardia—Etoposide—uterine cancer	0.000954	0.00142	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Etoposide—uterine cancer	0.000945	0.0014	CcSEcCtD
Icosapent ethyl—Pancreatitis—Epirubicin—uterine cancer	0.000945	0.0014	CcSEcCtD
Icosapent ethyl—Angina pectoris—Epirubicin—uterine cancer	0.000939	0.00139	CcSEcCtD
Icosapent ethyl—Anorexia—Etoposide—uterine cancer	0.000932	0.00138	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000929	0.00138	CcSEcCtD
Icosapent ethyl—Bronchitis—Epirubicin—uterine cancer	0.000927	0.00137	CcSEcCtD
Icosapent ethyl—Gastritis—Doxorubicin—uterine cancer	0.000913	0.00135	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00091	0.00135	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—uterine cancer	0.000898	0.00133	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—uterine cancer	0.000892	0.00132	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—uterine cancer	0.000892	0.00132	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—uterine cancer	0.000892	0.00132	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—uterine cancer	0.000874	0.0013	CcSEcCtD
Icosapent ethyl—Dyspnoea—Etoposide—uterine cancer	0.000872	0.00129	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—uterine cancer	0.000869	0.00129	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—uterine cancer	0.000869	0.00129	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—uterine cancer	0.000864	0.00128	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—uterine cancer	0.000859	0.00127	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—uterine cancer	0.000859	0.00127	CcSEcCtD
Icosapent ethyl—Vomiting—Dactinomycin—uterine cancer	0.000859	0.00127	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—uterine cancer	0.000857	0.00127	CcSEcCtD
Icosapent ethyl—Rash—Dactinomycin—uterine cancer	0.000852	0.00126	CcSEcCtD
Icosapent ethyl—Decreased appetite—Etoposide—uterine cancer	0.00085	0.00126	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Etoposide—uterine cancer	0.000844	0.00125	CcSEcCtD
Icosapent ethyl—Pain—Etoposide—uterine cancer	0.000836	0.00124	CcSEcCtD
Icosapent ethyl—Constipation—Etoposide—uterine cancer	0.000836	0.00124	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—uterine cancer	0.000824	0.00122	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—uterine cancer	0.00081	0.0012	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—uterine cancer	0.000806	0.0012	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Etoposide—uterine cancer	0.000806	0.0012	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—uterine cancer	0.000804	0.00119	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—uterine cancer	0.0008	0.00119	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—uterine cancer	0.000795	0.00118	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—uterine cancer	0.000795	0.00118	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—uterine cancer	0.000773	0.00115	CcSEcCtD
Icosapent ethyl—Body temperature increased—Etoposide—uterine cancer	0.000773	0.00115	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—uterine cancer	0.000766	0.00114	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—uterine cancer	0.000762	0.00113	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—uterine cancer	0.00075	0.00111	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—uterine cancer	0.000746	0.00111	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—uterine cancer	0.000715	0.00106	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—uterine cancer	0.000708	0.00105	CcSEcCtD
Icosapent ethyl—Asthenia—Etoposide—uterine cancer	0.000701	0.00104	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—uterine cancer	0.000692	0.00103	CcSEcCtD
Icosapent ethyl—Pruritus—Etoposide—uterine cancer	0.000692	0.00103	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—uterine cancer	0.000689	0.00102	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—uterine cancer	0.000682	0.00101	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—uterine cancer	0.000671	0.000996	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—uterine cancer	0.000658	0.000976	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—uterine cancer	0.000649	0.000964	CcSEcCtD
Icosapent ethyl—Dizziness—Etoposide—uterine cancer	0.000646	0.000959	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—uterine cancer	0.00064	0.00095	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—uterine cancer	0.000638	0.000946	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—uterine cancer	0.000631	0.000936	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—uterine cancer	0.000623	0.000924	CcSEcCtD
Icosapent ethyl—Vomiting—Etoposide—uterine cancer	0.000622	0.000922	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—uterine cancer	0.000621	0.000922	CcSEcCtD
Icosapent ethyl—Rash—Etoposide—uterine cancer	0.000616	0.000914	CcSEcCtD
Icosapent ethyl—Dermatitis—Etoposide—uterine cancer	0.000616	0.000914	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—uterine cancer	0.000608	0.000903	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—uterine cancer	0.000605	0.000898	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—uterine cancer	0.000603	0.000895	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—uterine cancer	0.000602	0.000893	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—uterine cancer	0.000601	0.000892	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—uterine cancer	0.00059	0.000876	CcSEcCtD
Icosapent ethyl—Cough—Epirubicin—uterine cancer	0.000586	0.000869	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—uterine cancer	0.00058	0.00086	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—uterine cancer	0.000576	0.000855	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—uterine cancer	0.000572	0.000848	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—uterine cancer	0.000572	0.000848	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—uterine cancer	0.000572	0.000848	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—uterine cancer	0.000565	0.000838	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—uterine cancer	0.00056	0.000831	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—uterine cancer	0.000559	0.000829	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—uterine cancer	0.000558	0.000828	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—uterine cancer	0.000557	0.000827	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—uterine cancer	0.000548	0.000813	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—uterine cancer	0.000548	0.000813	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—uterine cancer	0.000546	0.00081	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—uterine cancer	0.000544	0.000808	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—uterine cancer	0.000542	0.000804	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—uterine cancer	0.000539	0.0008	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—uterine cancer	0.000536	0.000796	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—uterine cancer	0.000535	0.000793	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—uterine cancer	0.00053	0.000786	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—uterine cancer	0.000529	0.000785	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—uterine cancer	0.000529	0.000785	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—uterine cancer	0.000529	0.000785	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—uterine cancer	0.000523	0.000775	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—uterine cancer	0.000522	0.000775	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—uterine cancer	0.000517	0.000767	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—uterine cancer	0.000507	0.000752	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—uterine cancer	0.000507	0.000752	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—uterine cancer	0.000504	0.000747	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000499	0.000741	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—uterine cancer	0.000499	0.00074	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—uterine cancer	0.000496	0.000735	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—uterine cancer	0.000495	0.000734	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—uterine cancer	0.00049	0.000727	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—uterine cancer	0.000489	0.000725	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—uterine cancer	0.000483	0.000717	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—uterine cancer	0.000482	0.000716	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—uterine cancer	0.000476	0.000707	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000473	0.000702	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—uterine cancer	0.000469	0.000695	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—uterine cancer	0.000469	0.000695	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000462	0.000685	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—uterine cancer	0.000459	0.00068	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—uterine cancer	0.000452	0.000671	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—uterine cancer	0.000452	0.00067	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—uterine cancer	0.000446	0.000662	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—uterine cancer	0.000441	0.000654	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000438	0.000649	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—uterine cancer	0.000434	0.000643	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—uterine cancer	0.000434	0.000643	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—uterine cancer	0.000433	0.000643	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—uterine cancer	0.000418	0.00062	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—uterine cancer	0.000401	0.000595	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—uterine cancer	0.000393	0.000583	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—uterine cancer	0.000388	0.000575	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—uterine cancer	0.000364	0.00054	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—uterine cancer	0.000362	0.000538	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—uterine cancer	0.000359	0.000532	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—uterine cancer	0.000348	0.000517	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—uterine cancer	0.000346	0.000513	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—uterine cancer	0.000345	0.000512	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—uterine cancer	0.000335	0.000497	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—uterine cancer	0.000322	0.000478	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—uterine cancer	0.00032	0.000474	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—uterine cancer	0.000319	0.000474	CcSEcCtD
